Cognitive impairment in patients after COVID-19
https://doi.org/10.25789/YMJ.2021.73.19
Abstract
The assessment of changes in the level of cognitive functions in patients who underwent COVID-19 was carried out. The analysis of more than 30 modern scientific studies for 2019-2021 showed that patients who had the new coronavirus infection of varying severity, there are significant changes in the level of cognitive functioning in the form of a decrease in memory, executive functions, attention, etc.
About the Authors
S. A. Galkin
Mental Health Research Institute, Tomsk NRMC
Russian Federation
Russian Federation
Galkin Stanislav A., PhD Student
A. G. Peshkovskaya
Mental Health Research Institute, Tomsk NRMC
Russian Federation
Russian Federation
Peshkovskaya Anastasia G., Researcher
S. A. Ivanova
Mental Health Research Institute, Tomsk NRMC
Russian Federation
Russian Federation
Ivanova Svetlana A., DM, Professor, Head of the Laboratory of Molecular Genetics and Biochemistry, Deputy Director for Science
Tomsk
N. A. Bokhan
Mental Health Research Institute;
Siberian State Medical University of Russia
Russian Federation
Russian Federation
Bokhan Nikolay A., DM, Professor, Аcademician of the Russian Academy of Sciences academician, RAS, Director;
head of the Department of psychiatry, psychotherapy, narcology with the course med. the psychology
Tomsk
References
1. Galkin S.A. The relationship of cognitive disorders with clinical features of alcohol dependence / S. A. Galkin, A. G. Peshkovskaya, O. V. Roshchina et al. // Yakut medical journal. – 2020. – №2. – Р. 62–65. doi:10.25789/YMJ.2020.70.19.
2. A Case of COVID–19 With Memory Impairment and Delayed Presentation as Stroke / A. Garg, A. Marji, S. Goyal [et al.] // Cureus. – 2020. – №8. – P. e10025. doi:10.7759/cureus.10025.
3. Ardila A. Executive dysfunction in COVID–19 patients / A. Ardila, D. Lahiri // Diabetes Metab Syndr. – 2020. – №5. – Р. 1377–1378. doi:10.1016/j.dsx.2020.07.032.
4. Baker H.A. The 'third wave': impending cognitive and functional decline in COVID–19 survivors / H.A. Baker, S.A. Safavynia, L.A. Evered // Br J Anaesth. – 2021. – №1. – Р. 44–47. doi:10.1016/j.bja.2020.09.045.
5. Characteristics and outcomes of 21 critically ill patients with COVID–19 in Washington State / M. Arentz, E. Yim, L. Klaff [et al.] // JAMA. – 2020. – №323. – Р. 1612. doi:10.1001/jama.2020.4326.
6. Chronic traumatic encephalopathy: neurodegeneration following repetitive concussive and subconcussive brain trauma / C.M. Baugh, J.M. Stamm, D.O. Riley [et al.] // Brain Imaging Behav. – 2012. – №2. – P. 244–254. doi:10.1007/s11682–012–9164–5.
7. COVID–19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features / N. Poyiadji, G. Shahin, D. Noujaim [et al.] // Radiology. – 2020. – №2. – P. 119–120. doi:10.1148/radiol.2020201187.
8. Dementia care in times of COVID–19: experience at Fundacio ACE in Barcelona / A. Benaque, M.J. Gurruchaga, C. Abdelnour [et al.] // Spain. J. Alzheimers Dis. – 2020. – №1. – Р. 33–40. doi:10.3233/jad–200547
9. Frequent neurocognitive deficits after recovery from mild COVID–19 / M.S. Woo, J. Malsy, J. Pöttgen [et al.] // Brain Communications. – 2020. – №2. – P. fcaa205. doi:10.1093/braincomms/fcaa205
10. Functional and cognitive outcomes after COVID–19 delirium / B.C. McLoughlin, A. Miles, T.E. Webb [et al.] // Eur. Geriatr. Med. – 2020. – №5. – P. 857–862. doi:10.1007/s41999–020–00353–8
11. Hampshire A. Cognitive deficits in people who have recovered from COVID–19 relative to controls: An N=84,285 online study / A. Hampshire // medRxiv. – 2020. – №10. – P. 96–103. doi:10.1101/2020.10.20.20215863
12. Hosey M.M. Survivorship after COVID–19 ICU stay / M.M. Hosey, D.M. Needham // Nat Rev Dis Primers. – 2020. – №6. – Р. 60. doi:10.1038/s41572–020–0201–1
13. Immediate and long–term consequences of COVID–19 infections for the development of neurological disease / M.T. Heneka, D. Golenbock, E. Latz [et al.] // Alz. Res. Therapy. – 2020. – №12. – Р. 69. doi:10.1186/s13195–020–00640–3
14. Impact of SARS–CoV–2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic / P.J. Serrano–Castro, G. Estivill–Torrús, P. Cabezudo–García [et al.] // Neurologia. – 2020. – №4. – Р. 245–251. doi:10.1016/j.nrl.2020.04.002.
15. Inflammation induced by infection potentiates tau pathological features in transgenic mice / M. Sy, M. Kitazawa, R. Medeiros [et al.] // Am. J. Pathol. – 2011. – №178. – Р. 2811–2822. doi:10.1016/j.ajpath.2011.02.012.
16. Jurado M.B. The elusive nature of executive functions: a review of our current understanding / M.B. Jurado, M. Rosselli // Neuropsychol Rev. – 2007. – №3. – P. 213–233. doi:10.1007/s11065–007–9040–z.
17. Long–Term Cognitive Impairment after Critical Illness / P.P. Pandharipande, T.D. Girard, J.C. Jackson [et al.] // N Engl J Med. – 2013. – №369. – Р. 1306–1316. doi:10.1056/NEJMoa1301372
18. Long–term neuroinflammation induced by influenza A virus infection and the impact on hippocampal neuron morphology and function / S. Hosseini, E. Wilk, K. Michaelsen–Preusse [et al.] // J. Neurosci. – 2018. – №38. – P. 3060–3080. doi:10.1523/JNEUROSCI.1740–17.2018.
19. Medium–term effects of SARS–CoV–2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post–hospital discharge / B. Raman, M. Cassar, E.M. Tunnicliffe [et al.] // medRxiv Preprint. – 2020. – №5. – P. 126. doi:10.1101/2020.10.15.20205054
20. Neurologic features in severe SARS–CoV–2 infection / J. Helms, S. Kremer, H. Merdji [et al.] // N Engl J Med. – 2020. – №23. – Р. 2268–2270. doi:10.1056/NEJMc2008597.
21. Neurological complications of coronavirus disease (COVID–19): encephalopathy / A. Filatov, P. Sharma, F. Hindi [et al.] // Cureus. – 2020. – №3. – P. e7352. doi: 10.7759/cureus.7352.
22. Neurological manifestations of hospitalized patients with COVID–19 in Wuhan, China: a retrospective case series study / L. Mao, M. Wang, S. Chen [et al.] // JAMA Neurol. – 2020. – №6. – P. 683–690. doi:10.1001/jamaneurol.2020.1127.
23. Ritchie K. The cognitive consequences of the COVID–19 epidemic: collateral damage / K. Ritchie, D. Chan, T. Watermeyer. // Brain Communications. – 2020. – №2. – P. 51. doi: 10.1093/braincomms/fcaa069
24. Self–reported depressive symptoms and memory complaints in survivors five years after ARDS / N. Adhikari, C.M. Tansey, M.P. McAndrews [et al.] // Chest. – 2011. – №140. – Р. 1484–1493. doi:10.1378/chest.11–1667.
25. The adult respiratory distress syndrome cognitive outcomes study / M.E. Mikkelsen, J.D. Christie, P.N. Lanken [et al.] // Am. J. Respir. Crit. Care Med. – 2012. – №185. – Р. 1307–1315. doi:10.1164/rccm.201111–2025OC.
26. The landscape of cognitive function in recovered COVID–19 patients / H. Zhou, S. Lu, J. Chen [et al.] // J Psychiatr Res. – 2020. – №129. – Р. 98–102. doi:10.1016/j.jpsychires.2020.06.022.
27. Two–year cognitive, emotional and quality of life outcomes in acute respiratory distress syndrome / R.O. Hopkins, L.K. Weaver, D. Collingridge [et al.] // Am. J. Respir. Crit. Care Med. – 2005. – №171. – Р. 340–347. doi:10.1164/ajrccm.172.6.958.
28. Wilcox C. Characterizing Cognitive Impairment in Patients Recovered from COVID–19 / C. Wilcox // J Psychiatr Res. – 2020. – №129. – P. 98. doi:10.1016/j.jpsychires.2020.06.022.
29. Ye M. Encephalitis as a clinical manifestation of COVID–19 / M. Ye, Y. Ren, T. Lv // Brain Behav Immun. – 2020. – №88. – P. 945–946. doi:10.1016/j.bbi.2020.04.017.
Review
For citations:
Galkin S.A., Peshkovskaya A.G., Ivanova S.A., Bokhan N.A. Cognitive impairment in patients after COVID-19. Yakut Medical Journal. 2021;(1):69-72. https://doi.org/10.25789/YMJ.2021.73.19
Views:
24
Email this article 